Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2026-01-03 @ 6:36 AM
Study NCT ID:
NCT02540759
Status:
COMPLETED
Last Update Posted:
2016-03-11
First Post:
2015-08-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response
Sponsor:
Réseau de Santé Vitalité Health Network
Organization:
Study Overview
Official Title:
Study of the Effect of Dose of Buglossoides Arvensis Oil on Eicosapentaenoic Acid Accrual and on the Inflammatory Response
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The effect of various doses of Buglossoides oil on the accrual of eicosapentaenoic acid (EPA) in blood and circulating cells will be investigated.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: